{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:11:31Z","timestamp":1777896691389,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274005"],"award-info":[{"award-number":["82274005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ijpddr.2025.100603","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T15:18:03Z","timestamp":1752592683000},"page":"100603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Pharmacokinetics and metabolism of artemisinin (ART) in Plasmodium yoelii: ART-heme adduct as a potential biomarker for its resistance"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6416-6098","authenticated-orcid":false,"given":"Shanshan","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9762-6828","authenticated-orcid":false,"given":"Kun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2025.100603_bib1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1126\/science.aax4735","article-title":"A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites","volume":"367","author":"Birnbaum","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2025.100603_bib2","doi-asserted-by":"crossref","first-page":"6935","DOI":"10.1021\/acs.biochem.8b00960","article-title":"Dihydroartemisinin-ferriprotoporphyrin IX adduct abundance in Plasmodium falciparum malarial parasites and the relationship to emerging artemisinin resistance","volume":"57","author":"Heller","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijpddr.2025.100603_bib3","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1002\/anie.201512062","article-title":"A click chemistry-based proteomic approach reveals that 1,2,4-trioxolane and artemisinin antimalarials share a common protein alkylation profile","volume":"55","author":"Ismail","year":"2016","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ijpddr.2025.100603_bib4","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ejmech.2018.12.007","article-title":"Current scenario of artemisinin and its analogues for antimalarial activity","volume":"163","author":"Kumari","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2025.100603_bib5","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00260-18","article-title":"Metabolism of piperaquine to its antiplasmodial metabolites and their pharmacokinetic profiles in healthy volunteers","volume":"62","author":"Liu","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2025.100603_bib6","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.016115","article-title":"A second mechanism employed by artemisinins to suppress Plasmodium falciparum hinges on inhibition of hematin crystallization","volume":"296","author":"Ma","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2025.100603_bib7","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1517\/13543784.14.9.1117","article-title":"The therapeutic potential of semi-synthetic artemisinin and synthetic endoperoxide antimalarial agents","volume":"14","author":"O'Neill","year":"2005","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ijpddr.2025.100603_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2022.102636","article-title":"The origins, isolation, and biological characterization of rodent malaria parasites","volume":"91","author":"Pattaradilokrat","year":"2022","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ijpddr.2025.100603_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.129700","article-title":"Novel ether derivatives of 11-azaartemisinins with high order antimalarial activity against multidrug-resistant Plasmodium yoelii in Swiss mice","volume":"103","author":"Rathi","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijpddr.2025.100603_bib10","doi-asserted-by":"crossref","first-page":"13676","DOI":"10.1073\/pnas.0500972102","article-title":"The antimalarial drug artemisinin alkylates heme in infected mice","volume":"102","author":"Robert","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2025.100603_bib11","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1128\/AAC.01064-13","article-title":"Correlation between Plasmodium yoelii nigeriensis susceptibility to artemisinin and alkylation of heme by the drug","volume":"57","author":"Robert","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2025.100603_bib12","doi-asserted-by":"crossref","first-page":"e591","DOI":"10.1016\/S1473-3099(24)00141-5","article-title":"The emergence of artemisinin partial resistance in Africa: how do we respond?","volume":"24","author":"Rosenthal","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpddr.2025.100603_bib13","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.2147\/DDDT.S118116","article-title":"Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold","volume":"10","author":"Rudrapal","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ijpddr.2025.100603_bib14","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1021\/jm401774f","article-title":"New orally active amino- and hydroxy-functionalized 11-azaartemisinins and their derivatives with high order of antimalarial activity against multidrug-resistant Plasmodium yoelii in Swiss mice","volume":"57","author":"Singh","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2025.100603_bib15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/AAC.46.1.105-109.2002","article-title":"Carrier-mediated partitioning of artemisinin into Plasmodium falciparum-infected erythrocytes","volume":"46","author":"Vyas","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2025.100603_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00109-24","article-title":"Artemisinin-resistant malaria","volume":"37","author":"White","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijpddr.2025.100603_bib17","series-title":"Guidelines for the Treatment of Malaria","year":"2023"},{"key":"10.1016\/j.ijpddr.2025.100603_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117032","article-title":"Novel frontiers through nitrogen substitution at 6th, 10th and 11th position of artemisinin: synthetic approaches and antimalarial activity","volume":"281","author":"Yadav","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2025.100603_bib19","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/1475-2875-13-214","article-title":"Auto-induction of phase I and phase II metabolism of artemisinin in healthy Chinese subjects after oral administration of a new artemisinin-piperaquine fixed combination","volume":"13","author":"Zang","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2025.100603_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.fitote.2017.05.015","article-title":"A novel dihydroxylated derivative of artemisinin from microbial transformation","volume":"120","author":"Zhan","year":"2017","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ijpddr.2025.100603_bib21","doi-asserted-by":"crossref","first-page":"6533","DOI":"10.2147\/IDR.S383127","article-title":"Polymorphisms in the K13-propeller gene in artemisinin-resistant Plasmodium in mice","volume":"15","author":"Zheng","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.ijpddr.2025.100603_bib22","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s12936-024-05163-y","article-title":"CYP3A4-mediated metabolism of artemisinin to 10\u03b2-hydroxyartemisinin with comparable anti-malarial potency","volume":"23","author":"Zhu","year":"2024","journal-title":"Malar. J."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320725000260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320725000260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:34:29Z","timestamp":1777624469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320725000260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":22,"alternative-id":["S2211320725000260"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2025.100603","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics and metabolism of artemisinin (ART) in Plasmodium yoelii: ART-heme adduct as a potential biomarker for its resistance","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2025.100603","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}],"article-number":"100603"}}